Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: An update from the Group for the Respect of Ethics and Excellence in Science (Osteoporosis International DOI: 10.1007/s00198-008-0670-7)
Publication
, Journal Article
Compston, J; Reid, DM; Boisdron, J; Brandi, ML; Burlet, N; Cahall, D; Delmas, PD; Dere, W; Devogelaer, JP; Fitzpatrick, LA; Flamion, B ...
Published in: Osteoporosis International
March 1, 2009
Duke Scholars
Published In
Osteoporosis International
DOI
EISSN
1433-2965
ISSN
0937-941X
Publication Date
March 1, 2009
Volume
20
Issue
3
Start / End Page
497 / 498
Related Subject Headings
- Endocrinology & Metabolism
- 4202 Epidemiology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 0903 Biomedical Engineering
Citation
APA
Chicago
ICMJE
MLA
NLM
Compston, J., Reid, D. M., Boisdron, J., Brandi, M. L., Burlet, N., Cahall, D., … Reginster, J. Y. (2009). Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: An update from the Group for the Respect of Ethics and Excellence in Science (Osteoporosis International DOI: 10.1007/s00198-008-0670-7). Osteoporosis International, 20(3), 497–498. https://doi.org/10.1007/s00198-008-0735-7
Compston, J., D. M. Reid, J. Boisdron, M. L. Brandi, N. Burlet, D. Cahall, P. D. Delmas, et al. “Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: An update from the Group for the Respect of Ethics and Excellence in Science (Osteoporosis International DOI: 10.1007/s00198-008-0670-7).” Osteoporosis International 20, no. 3 (March 1, 2009): 497–98. https://doi.org/10.1007/s00198-008-0735-7.
Compston J, Reid DM, Boisdron J, Brandi ML, Burlet N, Cahall D, et al. Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: An update from the Group for the Respect of Ethics and Excellence in Science (Osteoporosis International DOI: 10.1007/s00198-008-0670-7). Osteoporosis International. 2009 Mar 1;20(3):497–8.
Compston, J., et al. “Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: An update from the Group for the Respect of Ethics and Excellence in Science (Osteoporosis International DOI: 10.1007/s00198-008-0670-7).” Osteoporosis International, vol. 20, no. 3, Mar. 2009, pp. 497–98. Scopus, doi:10.1007/s00198-008-0735-7.
Compston J, Reid DM, Boisdron J, Brandi ML, Burlet N, Cahall D, Delmas PD, Dere W, Devogelaer JP, Fitzpatrick LA, Flamion B, Goel N, Korte S, Laslop A, Mitlak B, Ormarsdottir S, Ringe J, Rizzoli R, Tsouderos Y, Van Staa T, Reginster JY. Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: An update from the Group for the Respect of Ethics and Excellence in Science (Osteoporosis International DOI: 10.1007/s00198-008-0670-7). Osteoporosis International. 2009 Mar 1;20(3):497–498.
Published In
Osteoporosis International
DOI
EISSN
1433-2965
ISSN
0937-941X
Publication Date
March 1, 2009
Volume
20
Issue
3
Start / End Page
497 / 498
Related Subject Headings
- Endocrinology & Metabolism
- 4202 Epidemiology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 0903 Biomedical Engineering